Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the fatty liver treatment market?

The market for fatty liver treatment has seen robust growth in the past few years. The size of the market is projected to rise from $23.73 billion in 2024 to $25.12 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. The historical growth trend can be credited to factors such as the obesity outbreak, inactive lifestyles, poor nutrition, a lack of treatment alternatives, and awareness initiatives.

What will be the fatty liver treatment market size in the future?

The market size for fatty liver treatment is anticipated to experience robust expansion in the upcoming years, reaching a valuation of $33.07 billion in 2029, with a compound annual growth rate (CAGR) of 7.1%. The predicted growth during the forecast period can be linked to a rise in disease cases, increased spending on healthcare, a surge in diabetes and metabolic syndrome cases, and advancements in therapeutic innovations. Notable trends during the forecast timeline include the adoption of precision medicine techniques, programs aimed at lifestyle changes, specific treatments for Nash, non-invasive monitoring tools, and advancements in technology.

Get your fatty liver treatment market report here!

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

What main drivers are fueling expansion in the fatty liver treatment market?

The surge in the consumption of alcoholic beverages is predicted to boost the expansion of the fatty liver treatment market. Drinking alcohol, a mind-altering substance with sedative effects on the brain, refers to the intake of drinks containing alcohol. Consuming alcohol may exacerbate fatty liver disease and result in more serious liver-related conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For example, as per the HRB National Drugs Library, a government-funded organization based in Ireland, in 2022, alcohol intake in Scotland surged to 10.2 liters of pure alcohol per capita for individuals aged 15 and above. This represents a 7.6% increase in comparison to 2021, signaling a worrisome rise in alcohol consumption despite continued public health initiatives to curtail drinking. Consequently, the rise in the consumption of alcohol is fueling the progression of the fatty liver treatment market.

What key areas define the segmentation of the global fatty liver treatment market?

The fatty liver treatment market covered in this report is segmented –

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs

2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases

3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids, Calcineurin Inhibitors, mTOR Inhibitors

2) By Chemotherapy Drugs: Conventional Chemotherapy Agents, Novel Chemotherapeutics Under Investigation

3) By Targeted Therapy: Small Molecule Inhibitors, Monoclonal Antibodies

4) By Vaccines: Therapeutic Vaccines, Preventive Vaccines

5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs), Nucleos(t)ide Analogs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

Who are the dominant players expanding their reach in the fatty liver treatment market?

Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

How are evolving market trends shaping fatty liver treatment Strategies?

A current trend that is increasing in popularity within the fatty liver treatment market is product innovation, which major businesses use to secure a solid market hold. For instance, in March 2023, Akero Therapeutics, a biotech firm based in the U.S., saw promising Phase II results for efruxifermin, a product created for the treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) that have been diagnosed non-invasively. This differentiated Fc-FGF21 fusion protein imitates the biological activity of fibroblast growth factor 21 (FGF21), involved in regulating various metabolic systems and cellular procedures.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12581

Which regions are emerging as leaders in the fatty liver treatment market?

North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Chemical Surface Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemical-surface-treatment-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Fatty Acids Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fatty-acids-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: